Adjuvant Combinations of NKT Activator, CD40 Agent, CD40 Agonist, and Optional Antigen, the Use Through Inducing Synergistic Cellular Immunity

• 收藏
• 分享

专利权人:

IMMURX; INC.

发明人:

Cory AHONEN,Randolph NOELLE

申请号：

US14963946

公开号：

US20160158348A1

申请日:

2015.12.09

申请国别(地区):

US

年份:

2016

代理人:

摘要：

Adjuvant combinations comprising at least one NKT activator, such as alpha-galactosylceramide (α-Gal-Cer) or iGb3, a CD40 agonist and optionally an antigen are disclosed. The use of these immune adjuvants for treatment of various chronic diseases such as cancers is also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/